药品注册申请号:011665
申请类型:NDA (新药申请)
申请人:BAUSCH
申请人全名:BAUSCH HEALTH US LLC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 MESTINON PYRIDOSTIGMINE BROMIDE TABLET, EXTENDED RELEASE;ORAL 180MG Yes Yes AB 1959/01/12 Approved Prior to Jan 1, 1982 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2014/07/25 SUPPL-20(补充) Approval Manufacturing (CMC) STANDARD
2014/01/03 SUPPL-19(补充) Approval Manufacturing (CMC) STANDARD
2001/08/14 SUPPL-18(补充) Approval Manufacturing (CMC) STANDARD
2001/07/26 SUPPL-15(补充) Approval Labeling STANDARD
2001/07/26 SUPPL-13(补充) Approval Labeling STANDARD
2001/02/13 SUPPL-17(补充) Approval Manufacturing (CMC) STANDARD
1996/11/07 SUPPL-16(补充) Approval Manufacturing (CMC) STANDARD
1995/10/24 SUPPL-14(补充) Approval Manufacturing (CMC) STANDARD
1989/07/18 SUPPL-11(补充) Approval Manufacturing (CMC) STANDARD
1986/01/27 SUPPL-10(补充) Approval Labeling
1978/11/22 SUPPL-8(补充) Approval Manufacturing (CMC) STANDARD
1978/02/16 SUPPL-7(补充) Approval Manufacturing (CMC) STANDARD
1977/02/09 SUPPL-5(补充) Approval Manufacturing (CMC) STANDARD
1959/01/12 ORIG-1(原始申请) Approval Type 3 - New Dosage Form STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:PYRIDOSTIGMINE BROMIDE 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL 规格:180MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
011665 001 NDA MESTINON PYRIDOSTIGMINE BROMIDE TABLET, EXTENDED RELEASE;ORAL 180MG Prescription Yes Yes AB Approved Prior to Jan 1, 1982 BAUSCH
204737 001 ANDA PYRIDOSTIGMINE BROMIDE PYRIDOSTIGMINE BROMIDE TABLET, EXTENDED RELEASE;ORAL 180MG Prescription No No AB 2015/06/26 ALVOGEN
203184 001 ANDA PYRIDOSTIGMINE BROMIDE PYRIDOSTIGMINE BROMIDE TABLET, EXTENDED RELEASE;ORAL 180MG Prescription No No AB 2015/09/15 IMPAX LABS INC
205464 001 ANDA PYRIDOSTIGMINE BROMIDE PYRIDOSTIGMINE BROMIDE TABLET, EXTENDED RELEASE;ORAL 180MG Prescription No No AB 2017/08/15 RISING
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database